Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | TRAP1 | Q12931 | 2/20 | 0.46 |
| ▸ | CHRNA7 | P36544 | 7/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.43 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL286882 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Bromide SCHEMBL2446607 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Bromide SCHEMBL678415 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Bromide SCHEMBL362235 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Bromide SCHEMBL1866839 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Bromide SCHEMBL635580 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Bromide SCHEMBL8775234 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Bromide SCHEMBL164301 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Bromide SCHEMBL2979400 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Bromide SCHEMBL1963378 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0650732-B1 | NOVEL MEDICINAL COMPOSITION | KIRIN BREWERY (JP) | 2001-04-04 | — | — | EP | disclosed |
| US-6071884-A | ADMINISTERING TO THE PATIENT ATLEAST ONE ALPHA-GALACTOSYLCERAMIDE TO TREAT THROMBOCYTOPENIA | KIRIN BEER KABUSHIKI KAISHA (JP) | 2000-06-06 | — | — | US | disclosed |
| US-6017892-A | Method for accelerating marrow cell proliferation | KIRAN BEER KABUSHIKI KAISHA (JP) | 2000-01-25 | — | — | US | disclosed |
| US-5936076-A | ANTITUMOR/ANTICARCINOGENIC AGENTS; IMMUNOSTIMULATORS; THERAPY AGAINST INFECTIONS, AQUIRED IMMUNE DEFICIENCY SYNDROME | KIRIN BEER KABUSHIKI KAISHA (JP) | 1999-08-10 | — | — | US | disclosed |
| EP-0609437-B1 | NOVEL SPHINGOGLYCOLIPID AND USE THEREOF | KIRIN BREWERY (JP) | 1999-07-07 | — | — | EP | disclosed |
| US-5767092-A | Treatment of radiation-damaged bone marrow using galactosyl ceramides | KIRIN BEER KABUSHIKI KAISHA (JP) | 1998-06-16 | — | — | US | disclosed |
| EP-0650732-A1 | NOVEL MEDICINAL COMPOSITION | KIRIN BEER KABUSHIKI KAISHA (JP) | 1995-05-03 | — | — | EP | disclosed |
| EP-0609437-A1 | NOVEL SPHINGOGLYCOLIPID AND USE THEREOF | KIRIN BEER KABUSHIKI KAISHA (JP) | 1994-08-10 | — | — | EP | disclosed |
| US-4659859-A | HYPOTENSIVE AGENTS, ANTI-CANCER AGENTS, ANTIINFLAMMATORY AGENTS | ELI LILLY AND COMPANY (US) | 1987-04-21 | — | — | US | disclosed |